Manton W I, Malloy C R
Br J Ind Med. 1983 Feb;40(1):51-7. doi: 10.1136/oem.40.1.51.
Blood, serum, cerebrospinal fluid, and urine obtained from a patient before and after chelation therapy showed that (1) the ratio of Pb in his cerebrospinal fluid to that in his serum varied from 0.4 to 0.9 and was independent of serum Pb concentration; (2) the fraction of Pb in his serum fell linearly with decreasing blood Pb concentration and changed from 1.6% to 0.33% as his blood Pb concentration changed from 116 micrograms/dl (5.6 mumol/l) to 31 micrograms/dl (1.5 mumol/l); and (3) his renal clearance of Pb from serum varied from 5 ml/min to 36 ml/min. This high value was obtained 11 days after chelation and is attributed to large quantities of Sn in his urine promoting the excretion of Pb. Solder was identified in his stool after discovery of radio-opaque material in his bowel. The Pb isotope ratios of the solder were different from those in his urine when he was first admitted, and showed that he had ingested solder when he had returned home on weekend passes.
对一名患者在螯合治疗前后采集的血液、血清、脑脊液和尿液进行检测,结果显示:(1) 其脑脊液中铅与血清中铅的比值在0.4至0.9之间,且与血清铅浓度无关;(2) 血清中铅的比例随血铅浓度降低呈线性下降,当血铅浓度从116微克/分升(5.6微摩尔/升)降至31微克/分升(1.5微摩尔/升)时,该比例从1.6%变为0.33%;(3) 其血清中铅的肾脏清除率在5毫升/分钟至36毫升/分钟之间。这个高值是在螯合治疗11天后测得的,归因于其尿液中大量的锡促进了铅的排泄。在其肠道中发现不透射线物质后,在粪便中鉴定出焊料。首次入院时,焊料的铅同位素比值与尿液中的不同,表明他在周末回家时摄入了焊料。